![Ryan Cole](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Cole
Chief Operating Officer at
AURINIA PHARMACEUTICALS INC.
Net worth: 2 M $ as of 31/05/2026
Profile
Ryan Cole is currently Chief Operating Officer at Kezar Life Sciences, Inc. since 2026 and Chief Operating Officer at Aurinia Pharmaceuticals, Inc. since 2026.
Formerly, Mr. Cole was Senior Auditor at Ernst & Young LLP from 2009 to 2012 and Vice President-Operations at Odonate, Inc. from 2017 to 2021.
Mr. Cole completed an undergraduate degree at Santa Clara University in 2009.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/05/2026 | 116,144 ( 0.09% ) | 2 M $ | 31/05/2026 |
Ryan Cole active positions
| Companies | Position | Start |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chief Operating Officer | 23/03/2026 |
| KEZAR LIFE SCIENCES, INC. | Chief Operating Officer | 11/05/2026 |
Former positions of Ryan Cole
| Companies | Position | End |
|---|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | 01/05/2012 |
| ODONATE, INC. | Chief Operating Officer | - |
Training of Ryan Cole
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Odonate, Inc.
 Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Ryan Cole
